These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 17298737)
1. [Effects of Epstein-Barr virus latent membrane protein 1 mediated by nuclear factor-kappaB on transformation and tumorigenesis of rat-1 cells]. Zhang ZW; He ZM; Zhou M; Zhang Q; Yu YH; Chen ZC Ai Zheng; 2007 Feb; 26(2):118-22. PubMed ID: 17298737 [TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts. He Z; Xin B; Yang X; Chan C; Cao L Cancer Res; 2000 Apr; 60(7):1845-8. PubMed ID: 10766170 [TBL] [Abstract][Full Text] [Related]
3. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration. Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941 [TBL] [Abstract][Full Text] [Related]
4. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104 [TBL] [Abstract][Full Text] [Related]
5. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB. Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512 [TBL] [Abstract][Full Text] [Related]
6. [Construction and function analysis of a CTAR-2 region mutant of the Epstein-Barr virus-encoded latent membrane protein-1]. He ZM; Chen ZC Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):261-5. PubMed ID: 12621551 [TBL] [Abstract][Full Text] [Related]
7. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells. Liljeholm S; Hughes K; Grundström T; Brodin P J Gen Virol; 1998 Sep; 79 ( Pt 9)():2117-25. PubMed ID: 9747720 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817 [TBL] [Abstract][Full Text] [Related]
9. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Murono S; Yoshizaki T; Sato H; Takeshita H; Furukawa M; Pagano JS Cancer Res; 2000 May; 60(9):2555-61. PubMed ID: 10811139 [TBL] [Abstract][Full Text] [Related]
10. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB. Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943 [TBL] [Abstract][Full Text] [Related]
11. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1. Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478 [TBL] [Abstract][Full Text] [Related]
12. Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1. Yan Z; Yong-Guang T; Fei-Jun L; Fa-Qing T; Min T; Ya C Int J Biochem Cell Biol; 2004 Aug; 36(8):1473-81. PubMed ID: 15147726 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871 [TBL] [Abstract][Full Text] [Related]
15. Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein, BRAM1. Chung PJ; Chang YS; Liang CL; Meng CL J Biol Chem; 2002 Oct; 277(42):39850-7. PubMed ID: 12181323 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways. Zhang J; Jia L; Lin W; Yip YL; Lo KW; Lau VMY; Zhu D; Tsang CM; Zhou Y; Deng W; Lung HL; Lung ML; Cheung LM; Tsao SW J Virol; 2017 Mar; 91(6):. PubMed ID: 28053105 [TBL] [Abstract][Full Text] [Related]
17. NF-kappaB is required for cell death induction by latent membrane protein 1 of Epstein-Barr virus. Nitta T; Chiba A; Yamashita A; Rowe M; Israël A; Reth M; Yamamoto N; Yamaoka S Cell Signal; 2003 Apr; 15(4):423-33. PubMed ID: 12618217 [TBL] [Abstract][Full Text] [Related]
18. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Cahir McFarland ED; Izumi KM; Mosialos G Oncogene; 1999 Nov; 18(49):6959-64. PubMed ID: 10602470 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity. Liu MT; Chang YT; Chen SC; Chuang YC; Chen YR; Lin CS; Chen JY Oncogene; 2005 Apr; 24(16):2635-46. PubMed ID: 15829976 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases. Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]